Xuan Marian Thai

Array ( [id] => 4650997 [patent_doc_number] => 20080038253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Methods For Altering T Cell Diversity' [patent_app_type] => utility [patent_app_number] => 10/591212 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 7417 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038253.pdf [firstpage_image] =>[orig_patent_app_number] => 10591212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931217 [patent_doc_number] => 20050282252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof' [patent_app_type] => utility [patent_app_number] => 11/064174 [patent_app_country] => US [patent_app_date] => 2005-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 28701 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282252.pdf [firstpage_image] =>[orig_patent_app_number] => 11064174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111200 [patent_doc_number] => 20050208655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Blood cells having modified antigenicity' [patent_app_type] => utility [patent_app_number] => 11/049271 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18282 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208655.pdf [firstpage_image] =>[orig_patent_app_number] => 11049271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5296011 [patent_doc_number] => 20090010937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Membrane Attack Complexes Associated with Circulating Immune Complexes' [patent_app_type] => utility [patent_app_number] => 10/587819 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5343 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010937.pdf [firstpage_image] =>[orig_patent_app_number] => 10587819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945261 [patent_doc_number] => 20050197310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases' [patent_app_type] => utility [patent_app_number] => 11/045780 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17703 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197310.pdf [firstpage_image] =>[orig_patent_app_number] => 11045780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527226 [patent_doc_number] => 08043818 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Methods for detecting expression of human protease molecules' [patent_app_type] => utility [patent_app_number] => 11/045577 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25049 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/043/08043818.pdf [firstpage_image] =>[orig_patent_app_number] => 11045577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894430 [patent_doc_number] => 20060002969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Methods for reducing the foreign body reaction' [patent_app_type] => utility [patent_app_number] => 11/044640 [patent_app_country] => US [patent_app_date] => 2005-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7632 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002969.pdf [firstpage_image] =>[orig_patent_app_number] => 11044640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243448 [patent_doc_number] => 20050271651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Inhibition of bright function as a treatment for excessive immunoglobulin production' [patent_app_type] => utility [patent_app_number] => 11/040488 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 44778 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271651.pdf [firstpage_image] =>[orig_patent_app_number] => 11040488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243448 [patent_doc_number] => 20050271651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Inhibition of bright function as a treatment for excessive immunoglobulin production' [patent_app_type] => utility [patent_app_number] => 11/040488 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 44778 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271651.pdf [firstpage_image] =>[orig_patent_app_number] => 11040488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658118 [patent_doc_number] => 20080026980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Use of Agents Derived from Ceacam1 for the Treatment of Inflammatory Diseases' [patent_app_type] => utility [patent_app_number] => 10/583291 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8625 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20080026980.pdf [firstpage_image] =>[orig_patent_app_number] => 10583291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648432 [patent_doc_number] => 20060134164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Th2-inducing adjuvant treatment for osteolysis' [patent_app_type] => utility [patent_app_number] => 11/015926 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3880 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134164.pdf [firstpage_image] =>[orig_patent_app_number] => 11015926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4687704 [patent_doc_number] => 20080031885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Use of Goat Serum for Veterinary Treatment' [patent_app_type] => utility [patent_app_number] => 10/582452 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2830 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031885.pdf [firstpage_image] =>[orig_patent_app_number] => 10582452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5074749 [patent_doc_number] => 20070014724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Interferon alpha antibodies and their uses' [patent_app_type] => utility [patent_app_number] => 11/009410 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30271 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014724.pdf [firstpage_image] =>[orig_patent_app_number] => 11009410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6982804 [patent_doc_number] => 20050152874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Vaccine immunotherapy for immune suppressed patients' [patent_app_type] => utility [patent_app_number] => 11/006451 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12510 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152874.pdf [firstpage_image] =>[orig_patent_app_number] => 11006451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5241771 [patent_doc_number] => 20070020263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Medicine containing genetically modified antibody against chemokine receptor ccr4' [patent_app_type] => utility [patent_app_number] => 10/581413 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12228 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020263.pdf [firstpage_image] =>[orig_patent_app_number] => 10581413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5153906 [patent_doc_number] => 20070036789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Neutralizable Epitope of HGF and Neutralizing Antibody Binding to the Same' [patent_app_type] => utility [patent_app_number] => 10/578836 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7908 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036789.pdf [firstpage_image] =>[orig_patent_app_number] => 10578836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111176 [patent_doc_number] => 20050208631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Polypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the same' [patent_app_type] => utility [patent_app_number] => 10/966849 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13650 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208631.pdf [firstpage_image] =>[orig_patent_app_number] => 10966849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7591157 [patent_doc_number] => 07662929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Antibody that specifically binds hyaluronan synthase' [patent_app_type] => utility [patent_app_number] => 10/574903 [patent_app_country] => US [patent_app_date] => 2004-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 52559 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662929.pdf [firstpage_image] =>[orig_patent_app_number] => 10574903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5258714 [patent_doc_number] => 20070212346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Highly Concentrated Stabilized Igm Solution' [patent_app_type] => utility [patent_app_number] => 10/575192 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10586 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212346.pdf [firstpage_image] =>[orig_patent_app_number] => 10575192 [rel_patent_id] =>[rel_patent_doc_number] =>)